Robert Shawah
Founder at ACURX PHARMACEUTICALS, INC.
Net worth: 463 540 $ as of 31/03/2024
Profile
Robert G.
Shawah is the founder of Acurx Pharmaceuticals, Inc. (founded in 2017) and holds the title of Chief Financial Officer.
He also held the position of Director at Ameri100 Holdco, Inc. in 2018.
Prior to that, he served as Treasurer & Chief Accounting Officer at Dipexium Pharmaceuticals, Inc. from 2014 to 2017.
Additionally, he was Vice President & Partner at Baldwin Pearson & Co., Inc. in 2013.
Mr. Shawah obtained his undergraduate degree from Bucknell University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/04/2024 | 189,200 ( 1.31% ) | 463 540 $ | 31/03/2024 |
Robert Shawah active positions
| Companies | Position | Start |
|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Founder | 01/07/2017 |
Former positions of Robert Shawah
| Companies | Position | End |
|---|---|---|
Ameri100 Holdco, Inc.
 Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Director/Board Member | 01/12/2018 |
Dipexium Pharmaceuticals, Inc.
 Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/04/2017 |
| Baldwin Pearson & Co., Inc. | Corporate Officer/Principal | 01/01/2013 |
Training of Robert Shawah
| Bucknell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Health Technology |
| Acurx Pharmaceuticals, Inc. | |
Ameri100 Holdco, Inc.
Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Miscellaneous |
| Baldwin Pearson & Co., Inc. |
- Stock Market
- Insiders
- Robert Shawah